OABI · OmniAb, Inc. · Metrics
$5.08
+0.03 (+0.59%)
At close · Nov 18
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$740.97M
Shares
145.86M
Volume · Nov 18
1.22M
Avg daily vol (3M)
1.48M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
OABI metrics
78 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$5.08
Market cap
$740.97M
Price action
23 metricsPrice change (1W)
-0.4%
Price change (30D)
+8.3%
Price change (3M)
+21.2%
Price change (6M)
+96.9%
Price change (YTD)
+174.6%
Price change (1Y)
+215.5%
Trailing year
Price change (5Y)
-49.0%
52-week high
$5.30
52-week low
$1.36
Change from 52-week high
-4.2%
Change from 52-week low
+273.5%
Annualized volatility
75.2%
Annualized volatility (3M)
69.5%
Implied volatility (30D)
92.4%
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
1.3
RSI (14D)
54.3
Price vs SMA 50
+6.0%
Price vs SMA 200
+74.7%
Avg volume (3M)
1.48M
Relative volume
0.8
Average dollar volume
$7.04M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
145.86M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
16.8×
reciprocal yield 5.9%
EV / EBITDA
—
EV / EBIT
—
P / sales
18.4×
reciprocal yield 5.4%
P / book
3.0
reciprocal yield 33.6%
FCF yield
0.3%
TTM · current market cap
Buyback yield
—
P / FCF
311.3
reciprocal yield 0.3%
P / operating cash flow
277.9
reciprocal yield 0.4%
Earnings yield
-5.9%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
12.6×
reciprocal yield 8.0%
EV / revenue historical average (5Y)
11.7×
reciprocal yield 8.5%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-10-30
Profitability
9 metricsGross margin
—
Operating margin
-115.9%
Trailing 12 months
Net margin
-108.1%
Gross profit (TTM)
—
Operating profit (TTM)
−$46.60M
Net income (TTM)
−$43.47M
Trailing 12 months
Diluted EPS (TTM)
$-0.34
FCF margin
5.9%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+78.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$40.21M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+12.7%
Year over year · more shares
Revenue CAGR (3Y)
-31.9%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-17.4%
Return on assets
-14.9%
Debt / equity
0.0
Current ratio
4.2
EBITDA (TTM)
−$47.22M
Free cash flow (TTM)
$2.38M
Quick ratio
4.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$22.88M
Latest balance sheet
Cash & equivalents
$22.88M
Total assets
$290.92M
Total debt
$0
Cash flow & spend
7 metricsOperating cash flow (TTM)
$2.67M
Capital expenditures (TTM)
$286,000
R&D (TTM)
$42.69M
SG&A (TTM)
—
Stock compensation (TTM)
$13.16M
R&D / revenue
106.2%
Stock compensation / revenue
32.7%
Ownership (13F)
9 metrics13F filers
174
13F filer change QoQ
+31
Institutional ownership
49.8%
Conviction holders (share of 13F filers)
1.7%
Crowding (high-turnover and private-fund holders)
21.4%
Private-fund adviser ownership
19.9%
Active holders' share change QoQ
+23.4%
Holder tenure
8.4
Price vs estimated holder cost
+46.9%
Ownership (registered funds)
1 metricsIndex-fund ownership
7.1%
Short interest
3 metricsShort interest
5.5%
Latest settlement · 5.2 days to cover
Days to cover
5.2d
Short-squeeze score
56 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1846253
CUSIP
68218J103
13F (30d)
179 filings
167 filers
Visit website
Investor relations